Dolby Laboratories (DLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 577,752 | 778,624 | 824,356 | 708,658 | 817,966 |
| Marketable Securities | N/A | 127,321 | 115,863 | 140,823 | 139,148 |
| Receivables | 315,465 | 285,843 | 282,131 | 293,228 | 262,245 |
| Inventories | 33,728 | 34,716 | 35,797 | 37,568 | 35,623 |
| Other current assets | 197,478 | 190,803 | 243,170 | 217,559 | 182,130 |
| TOTAL | $1,194,417 | $1,468,655 | $1,551,738 | $1,451,355 | $1,487,804 |
| Non-Current Assets | |||||
| PPE Net | 479,109 | 477,686 | 481,492 | 479,321 | 481,581 |
| Investments And Advances | 89,267 | 117,901 | 127,973 | 92,876 | 97,812 |
| Intangibles | 967,722 | 553,096 | 560,801 | 570,329 | 575,836 |
| Other Non-Current Assets | 379,413 | 356,297 | 322,724 | 341,648 | 336,733 |
| TOTAL | $1,915,511 | $1,504,980 | $1,492,990 | $1,484,174 | $1,491,962 |
| Total Assets | $3,109,928 | $2,973,635 | $3,044,728 | $2,935,529 | $2,979,766 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 17,380 | 16,413 | 19,727 | 14,395 | 20,925 |
| Accrued Expenses | 347,529 | 280,611 | 362,883 | 327,186 | 351,399 |
| Other current liabilities | 31,644 | 32,650 | 37,702 | 33,404 | 31,505 |
| TOTAL | $417,836 | $354,536 | $442,902 | $394,096 | $422,226 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 204,903 | 170,456 | 163,755 | 178,523 | 184,634 |
| TOTAL | $205,199 | $171,667 | $164,139 | $179,123 | $185,356 |
| Total Liabilities | $623,035 | $526,203 | $607,041 | $573,219 | $607,582 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 95,436 | 95,348 | 95,835 | 95,579 | 95,276 |
| Common Shares | 94 | 94 | 94 | 94 | 94 |
| Retained earnings | 2,496,255 | 2,462,928 | 2,449,876 | 2,367,182 | 2,391,990 |
| Other shareholders' equity | -9,456 | -15,590 | -12,283 | -4,966 | -19,900 |
| TOTAL | $2,486,893 | $2,447,432 | $2,437,687 | $2,362,310 | $2,372,184 |
| Total Liabilities And Equity | $3,109,928 | $2,973,635 | $3,044,728 | $2,935,529 | $2,979,766 |